Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Development

Phase III Trials

Olema Soars on Roche SERD Win, Then Slips on Planned Stock Offering

Investor enthusiasm cooled after Olema moved to raise capital, heightening dilution concerns.